Codman enters into the programmable implantable drug pump market in Europe with the introduction of the MEDSTREAM™ Programmable Infusion System, the first new pump technology for chronic intractable pain and spasticity in 20 years.
Entering into the growing aging-spine market, DePuy Spine introduces CONFIDENCE SPINAL CEMENT SYSTEM™ for vertebral compression fractures. DePuy Orthopaedics launches new joint-replacement products that include TRI-LOCK® Bone Preservation Stem, a bone-preserving hip stem with proprietary GRIPTION™ technology for stability, and enhancements to the SIGMA® Knee System.
The DePuy Family of Companies proudly supports the role of Johnson & Johnson as an Official Partner of the Beijing 2008 Olympic and Paralympic Games.
DePuy Mitek lays the groundwork for increased global sports medicine awareness and treatment, training orthopaedic surgeons in China and creating long-term educational opportunities, as well as enhanced awareness of the sports medicine continuum of care.
Construction begins on The DePuy Institute, LLC in Raynham, Massachusetts. This cutting edge facility will play a vital role in DePuy’s ability to provide customers and employees training, technology and physical space to learn about the latest advances in orthopaedic and neurological care.
The state-of-the-art DePuy manufacturing plant in Suzhou, China officially begins operations, establishing production for the Medical Device & Diagnostics sector of Johnson & Johnson in China and emerging markets in the region. An Innovation Centre is established at DePuy Ireland's Cork facility with plans to carry out next generation product and process development.
Codman & Shurtleff, Inc. integrates the former Cordis Neurovascular into the business, forming Codman Neurovascular and creating the platform for a global neuroscience device company.